<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="dyaa052-T1" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <p>Epidemiologic measures used to characterize the HCV epidemic and its trends, with a focus on the role of PAT exposure in the HCV epidemic of Egypt</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col valign="top" align="left" span="1"/>
   <col valign="top" align="left" span="1"/>
  </colgroup>
  <thead>
   <tr>
    <th align="center" rowspan="1" colspan="1">Measure</th>
    <th align="center" rowspan="1" colspan="1">Definition</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">HCV antibody (Ab) prevalence</td>
    <td rowspan="1" colspan="1">Proportion of a given population who are positive for HCV Ab, i.e. proportion of the population who have ever been infected with HCV</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Annual number of new HCV infections (also known as HCV incidence)</td>
    <td rowspan="1" colspan="1">Number of new HCV infections in a given population over the duration of a year</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">HCV-incidence rate (also known as force of infection or hazard rate of infection)</td>
    <td rowspan="1" colspan="1">Number of new HCV infections per person-time of the at-risk population, i.e. HCV incidence divided by the population size of the at-risk susceptible population</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Population proportion of PAT exposure</td>
    <td rowspan="1" colspan="1">Proportion of the population who have ever been exposed to PAT</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Proportion of prevalent infections strictly attributed to PAT</td>
    <td rowspan="1" colspan="1">Number of living individuals who have ever been infected by HCV due to PAT exposure divided by the total number of living individuals who have ever been infected by HCV regardless of the mode of transmission</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Proportion of new HCV infections strictly attributed to PAT</td>
    <td rowspan="1" colspan="1">HCV incidence due to PAT exposure divided by the total HCV incidence regardless of the mode of transmission</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tblfn1">
   <p>HCV, hepatitis C virus; PAT, parenteral antischistosomal therapy; Ab, antibody.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
